Cell and Gene Therapy Market Size, Trends, Industry Report, Key Player, Major Segments, and Forecast
The key highlights of the report include:
Market Overview (2016-2031)
- Forecast CAGR (2023-2031): 19.02%
The global cell and gene therapy market is expected to grow at a significant rate during the forecast period. The market growth is attributed to the increasing prevalence of chronic diseases such as cancer, genetic disorders, and others, rising investments in research and development, and increasing adoption of advanced technologies in healthcare.
Get a Free Sample Report with Table of Contents- https://www.expertmarketresearch.com/reports/cell-and-gene-therapy-cgt-market/requestsample
North America is expected to dominate the global cell and gene therapy market owing to the presence of a large number of key players in the region, advanced healthcare infrastructure, and increasing government funding for research and development. The Asia Pacific region is expected to grow at the highest rate during the forecast period due to the increasing adoption of advanced technologies in healthcare, rising healthcare expenditure, and the presence of a large patient population.
Europe is expected to hold a significant share of the global cell and gene therapy market due to the presence of a large number of key players in the region and increasing government funding for research and development.
Overall, the global cell and gene therapy market is expected to witness a significant growth rate during the forecast period due to the increasing prevalence of chronic diseases, rising investments in research and development, and increasing adoption of advanced technologies in healthcare.
Cell and Gene Therapy Industry Definition and Major Segments
Cell and gene therapy refers to the use of living cells and genetic material to treat or prevent diseases. This can include the use of stem cells to regenerate damaged tissue, the use of genetically modified cells to attack cancer cells, and the delivery of therapeutic genes to correct genetic disorders. Cell and gene therapy is a rapidly growing field of medicine that holds great promise for the treatment of a wide range of diseases.
Market Breakup by Therapeutic Class
- Rare Diseases
- Oncology
- Haematology
- Cardiology
- Ophthalmology
- Neurology
- Others
Market Breakup by Type
- Cell Therapy Types
- Autologous Cell Therapy
- Autogenic Cell Therapy
- Ex-vivo Cell Therapy
- In-vivo Cell Therapy
- Gene Therapy Types
- Somatic Cell Gene Therapy
- Germline Gene Therapy
- Ex-vivo Gene Therapy
- In-vivo Gene Therapy
Market Breakup by Product Type
- Yescarta
- Provenge
- Luxtura
- Kymriah
- Imlygic
- Gintuit
- MACI
- Laviv
- Gendicine
- Oncorine
- Neovasculgen
- Strimvelis
- Invossa
- Zolgenesma
- Tecartus
- Lisocel
- Zyntelego
- Others
Market Breakup by End User
- Hospitals
- Ambulatory Surgical Centres
- Wound Care Centres
- Cancer Care Centres
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- Latin America
Read Full Report with Table of Contents- https://www.expertmarketresearch.com/reports/cell-and-gene-therapy-cgt-market
Cell and Gene Therapy Market Trends
The growth of the cell and gene therapy market is driven by advances in technology and research, as well as increasing investment in the field. The increasing understanding of genetic disorders and the development of new genetic engineering techniques, such as CRISPR, have led to the development of more targeted and effective therapies.
The use of stem cells in regenerative medicine has the potential to revolutionize the treatment of a wide range of diseases. The growing prevalence of chronic diseases, such as cancer and genetic disorders, is also driving demand for cell and gene therapies. The increasing ageing population, coupled with the high costs of traditional therapies, is also expected to drive the market.
Furthermore, increasing government funding and collaborations between pharmaceutical companies and academic institutions are also driving the growth of the market. The increasing number of clinical trials and FDA approvals for cell and gene therapy products is also expected to drive market growth. However, the high cost of these therapies and the lack of reimbursement options may pose a challenge to market growth.
Key Market Players
The major players in the cell and gene therapy market report are:
- Amgen, Inc.
- Bluebird Bio, Inc.
- Castle Creek Pharmaceutical Holdings
- Kite Pharma, Inc.
- Novartis AG
- Orchard Therapeutics plc.
- Pfizer, Inc.
- Spark Therapeutics, Inc.
- Vericel Corporation
- Dendreon Pharmaceuticals LLC.
- Human Stem Cells Institute
- Dendreon Pharmaceuticals LLC.
- Kolon Tissuegene Inc.
- Organogenesis Holdings Inc.
- Renova Therapeutics.
- Others
The report studies the latest updates in the market, along with their impact across the market. It also analyses the market demand, together with its price and demand indicators. The report also tracks the market on the bases of SWOT and Porter’s Five Forces Models.
About Us:
Expert Market Research (EMR) is leading market research company with clients across the globe. Through comprehensive data collection and skilful analysis and interpretation of data, the company offers its clients extensive, latest, and actionable market intelligence which enables them to make informed and intelligent decisions and strengthen their position in the market. The clientele ranges from Fortune 1000 companies to small and medium scale enterprises.
EMR customises syndicated reports according to clients’ requirements and expectations. The company is active across over 15 prominent industry domains, including food and beverages, chemicals and materials, technology and media, consumer goods, packaging, agriculture, and pharmaceuticals, among others.
Over 3000 EMR consultants and more than 100 analysts work very hard to ensure that clients get only the most updated, relevant, accurate and actionable industry intelligence so that they may formulate informed, effective, and intelligent business strategies and ensure their leadership in the market.
Media Contact:
Company Name: Claight Corporation
Contact Person: Frara Prih, Corporate Sales Specialist – U.S.A.
Email: sales@expertmarketresearch.com
Toll Free Number: +1-415-325-5166 | +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com
0 Comments:
Post a Comment